Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
about
G-CSF and GM-CSF in NeutropeniaHematopoietic growth factors in clinical hematology.Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation.Severe neutropenia: a diagnostic approachGranulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.Management of Kostmann syndrome in the G-CSF era.A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.Angiotensin II increases host resistance to peritonitis.Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes.Neutrophil disorders and their management.Influences of systemic diseases on periodontitis in children and adolescents.Haematopoietic growth factors in children with neutropenia.The investigation and management of chronic neutropenia in children.History of pediatric hematology oncology.G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation.Recombinant hemopoietic growth factors: comparative hemopoietic response in younger and older subjects.Hemopoietic growth factors: a review.Clinical applications of granulocyte colony stimulating factor (G-CSF).Leukocyte integrin activation mediates transient neutropenia after G-CSF administration.The colony-stimulating factors and cancer.Paradoxical drop in circulating neutrophil count following granulocyte-colony stimulating factor and stem cell factor administration in rhesus macaques.G-CSF and GM-CSF in clinical trialsThe Jeremiah Metzger lecture. Regulation of hematopoiesis.The role of colony-stimulating factors in bone marrow transplantation.Thyrotoxicosis and antithyroid drugs.Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events.A case of systemic amyloidosis associated with cyclic neutropenia.How I manage children with neutropenia.Severe congenital neutropenias.Congenital cyclic neutropenia.Cyclic neutropenia: an unusual disorder of granulopoiesis effectively treated with recombinant granulocyte colony-stimulating factor.Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.Use of cytokines in clozapine-induced agranulocytosis.Periodontal implications: medically compromised patients.Progenitor cell self-renewal and cyclic neutropenia.Understanding, treating and avoiding hematological disease: better medicine through mathematics?Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis.Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.Cytokines in hematopoiesis.Risks of rhG-CSF treatment in drug-induced agranulocytosis
P2860
Q26800954-B3A60FDB-7F2F-4B24-9F77-1240E9678BC0Q30444416-25223202-AEA9-4796-B1F9-0A6604BEE46EQ33372274-D2688299-E0AF-4B30-B450-363F14CDA899Q33727491-E333F7C0-4FD9-4C55-B21B-AD60F69DD885Q33780538-2D6F0889-FEFF-491E-8A41-F71B39388D1FQ33962053-B32BE643-DDBB-401F-AC44-7564F659F681Q33998299-A0899B34-1D73-45DE-83CE-836E473768C6Q33998510-1800C7BF-3460-440E-9FAC-64454E0AC254Q34033152-FF5C4CC1-7461-4431-A6CF-5262813ABC42Q34197117-38C03E9E-C7B2-4896-9B02-307811A76816Q34308329-54F19B47-4C50-4367-A892-00A07381C022Q34527650-AC19A54C-36D3-4B5C-9172-B39A0FDF273CQ34567825-226AB8C0-9F70-4F19-9E7F-32924542FB6DQ35001654-8ACFF339-6192-47ED-9D08-E6B860FCF0B4Q35102238-F356E8E7-E65C-4F64-8D53-A482B670FD69Q35310404-3B44A0F6-B8E4-47E8-9D9B-1D08DC740B50Q35328369-968893E4-A856-4E02-B7DE-96BD41E1C8BAQ35337958-DCB3336D-B37B-4843-BE07-E8A8FBDA0D4CQ35483752-AF6475D1-AF1A-4AA7-B6DE-E81D1D674BC1Q35936937-95607F84-3D8A-4175-8FE6-AD09625477A4Q35941632-15F332E4-19A2-4E40-B521-1D92954F0A68Q36631539-251426A1-C6F2-4E4D-95A1-8B15E8AC4031Q36647093-3198C103-0FC8-43B8-84E8-D21D209A72E6Q36669960-AE78FD41-B010-4770-AA09-BE88F65B8535Q36727866-540D1C63-9756-4F5C-861E-ED1E6620B980Q37618366-848A5A69-BDD1-485A-B330-5636FD5A441AQ38478889-1858155F-FF37-451B-8264-51FDA7C75C98Q39248493-4D855EBD-0752-43DB-BAD9-2CB1087261A5Q39359222-60A36A17-14CA-4E68-82E2-824D3DB9FEB5Q40401383-76FF3181-2A95-4F5A-950F-13FD6615A548Q40592211-75C8A90E-FF4F-423F-9D25-BFCD348FB39CQ40844626-1AB9C985-C966-4B18-ABD1-C35ECDEDEB3EQ41102273-B278A088-677B-4047-9970-EB1F0C5D527CQ41444849-A690CE17-2C4A-4C2E-9E95-C5DE743D6CADQ41503351-1EBE7A77-AE20-471B-894E-A0F9A2E01A66Q41742420-04C1C703-CBC3-470D-AB02-4B812F8C141DQ45001942-2DABE622-E4A7-4B0F-A7F1-6027DF30A001Q47324057-F9E02513-28F6-471A-847D-5E0893F03E78Q47912530-716AF5DC-2FF6-427B-9115-E5FA825449ADQ57245401-5E278448-80E7-4C41-9EE4-88DDCAD9D438
P2860
Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
@en
type
label
Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
@en
prefLabel
Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
@en
P2093
P1476
Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
@en
P2093
P304
P356
10.1056/NEJM198905183202003
P407
P577
1989-05-01T00:00:00Z